by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Hubei Gedian Humanwell Pharmaceutical Co., Ltd. Warning Letter Details

Warning Letter

Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

Hubei Gedian Humanwell Pharmaceutical Co., Ltd., No. 25 Juxian Road Gedian Economic Development District Ezhou Shi Hubei Sheng , 436070 China

Issue DateJune 03, 2026

FEI Number3004117486

Violations3

CountryChina

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Hubei Gedian Humanwell Pharmaceutical Co., Ltd. FDA Warning Letter, June 3, 2026